Angiodynamics (ANGO) Retained Earnings (2016 - 2025)
Historic Retained Earnings for Angiodynamics (ANGO) over the last 17 years, with Q4 2025 value amounting to -$446.4 million.
- Angiodynamics' Retained Earnings fell 661.75% to -$446.4 million in Q4 2025 from the same period last year, while for Nov 2025 it was -$446.4 million, marking a year-over-year decrease of 661.75%. This contributed to the annual value of -$429.2 million for FY2025, which is 860.14% down from last year.
- Angiodynamics' Retained Earnings amounted to -$446.4 million in Q4 2025, which was down 661.75% from -$440.1 million recorded in Q3 2025.
- In the past 5 years, Angiodynamics' Retained Earnings registered a high of -$112.4 million during Q1 2021, and its lowest value of -$446.4 million during Q4 2025.
- In the last 5 years, Angiodynamics' Retained Earnings had a median value of -$191.7 million in 2023 and averaged -$264.7 million.
- In the last 5 years, Angiodynamics' Retained Earnings plummeted by 29806.16% in 2021 and then skyrocketed by 376.04% in 2023.
- Angiodynamics' Retained Earnings (Quarter) stood at -$147.2 million in 2021, then decreased by 22.23% to -$179.9 million in 2022, then dropped by 7.85% to -$194.0 million in 2023, then crashed by 115.82% to -$418.7 million in 2024, then dropped by 6.62% to -$446.4 million in 2025.
- Its Retained Earnings was -$446.4 million in Q4 2025, compared to -$440.1 million in Q3 2025 and -$429.2 million in Q2 2025.